
About EyekareKilitch
EyekareKilitch is a Healthcare company based in Mumbai (India) founded in 2010. It manufactures ophthalmic drugs, eye drops, and tablets for vision health in India. It operates on a B2B model. The company has 55 employees. EyekareKilitch offers products and services including Moxieye-PFS, Oxyvision Tablet, GATIEYE-HS, and HALOEYE. Its focus areas include Pharmaceuticals, Medical Innovations, Preservative-Free Technology and Ophthalmology. Its legal entity in India is Eye Kare Kilitch Limited (U24297MH2009PLC198224).
Company details
EyeKare Kilitch is a pharmaceutical company focused on ophthalmology, developing and producing eye care products like drops and tablets using innovative technologies. They operate in-house manufacturing facilities in Mumbai, India, and serve patients nationwide through doctor networks and RD efforts. Their activities emphasize quality compliance and accessibility for optimal vision health.
- Headquarters Mumbai, India
- Employees 55
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website eyekarekilitch.com
- Legal Name Eye Kare Kilitch Limited
- Date of Incorporation 31 Dec, 2009
- Jurisdiction Mumbai, Maharashtra, India
- Net Loss-₹1.1 Lakh
FY 2023 · 0% margin
- EBITDA-₹1.1 Lakh
FY 2023 · 0% margin
- Employee Count55
Associated legal entities of EyekareKilitch
EyekareKilitch operates through Eye Kare Kilitch Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eye Kare Kilitch Limited CIN U24297MH2009PLC198224 | Active | 31 Dec 2009 | Mumbai, Maharashtra | 55 | 6 | View details |
Products & Services of EyekareKilitch
EyekareKilitch offers a comprehensive portfolio of products and services, including Moxieye-PFS, Oxyvision Tablet, GATIEYE-HS, and HALOEYE.
Moxifloxacin solution for treating eye infections
Antioxidant tablet supporting vision health
Gatifloxacin drop for ophthalmic conditions
Sodium hyaluronate solution for eye lubrication
Board of directors of Eye Kare Kilitch Limited (EyekareKilitch)
Eye Kare Kilitch Limited is the primary company behind EyekareKilitch. The board of Eye Kare Kilitch Limited currently have 6 directors; the longest-serving is Paresh Prataprai Mehta, appointed in 2009. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Paresh Prataprai Mehta DIN 00148004 | Managing Director | 31 Dec 2009 | 16 yrs 10 mo | Eye Kare Kilitch Limited |
| Mukesh Damji Shah DIN 00893087 | Director | 30 Jun 2010 | 16 yrs 4 mo | Eye Kare Kilitch Limited |
| Divya Paresh Mehta DIN 06391672 | Director | 14 May 2013 | 13 yrs 6 mo | Eye Kare Kilitch Limited |
| Neha Paresh Mehta DIN 00148105 | Director | 14 May 2013 | 13 yrs 6 mo | Eye Kare Kilitch Limited |
| Pradyumna Upendra Pande DIN 06876992 | Director | 27 May 2014 | 12 yrs 5 mo | Eye Kare Kilitch Limited |
| Mukesh Manmohandas Agashiwala DIN 06875336 | Director | 01 Dec 2014 | 11 yrs 11 mo | Eye Kare Kilitch Limited |
Financials of EyekareKilitch
Figures of Eye Kare Kilitch Limited, the primary company behind EyekareKilitch, for FY 2023. Net loss was -₹1.1 Lakh (0% margin). EBITDA was -₹1.1 Lakh (0% margin). Revenue has grown at a compounded annual rate of -100% over five years.
- -₹1.1 LakhNet loss · 0% margin
- -₹1.1 LakhEBITDA · 0% margin
- ₹5.00 CrPaid-up capital
- 55Employees (provident fund records)
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Eye Kare Kilitch Limited are on its company page.
Detailed financial statements for EyekareKilitch
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as EyekareKilitch (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 74.68 M | 1,618 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EyekareKilitch
EyekareKilitch was founded in 2010.
EyekareKilitch is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
EyekareKilitch has 55 employees.
EyeKare Kilitch is a pharmaceutical company focused on ophthalmology, developing and producing eye care products like drops and tablets using innovative technologies. They operate in-house manufacturing facilities in Mumbai, India, and serve patients nationwide through doctor networks and RD efforts. Their activities emphasize quality compliance and accessibility for optimal vision health.
EyekareKilitch offers Moxieye-PFS, Oxyvision Tablet, GATIEYE-HS, and HALOEYE.
EyekareKilitch operates through Eye Kare Kilitch Limited.
The legal entities of EyekareKilitch currently have 6 directors, including Divya Paresh Mehta, Paresh Prataprai Mehta, Mukesh Manmohandas Agashiwala and others.